中国消化道出血用药行业市场规模测算逻辑模型 头豹词条报告系列

Investment Rating - The report does not explicitly state an investment rating for the gastrointestinal bleeding drug industry in China. Core Insights - The market size for gastrointestinal bleeding drugs in China is projected to grow from 42 billion RMB in 2018 to 86 billion RMB by 2027, reflecting a compound annual growth rate (CAGR) of approximately 6.15% [21]. - The number of patients with upper gastrointestinal bleeding is expected to increase from 2.67 million in 2018 to 9.17 million by 2027, indicating a significant growth trend [21]. - The annual cost of medication for upper gastrointestinal bleeding remains stable at 6.6 RMB per patient from 2018 to 2027 [29]. - The prevalence of upper gastrointestinal bleeding is projected to rise from 0.19% in 2018 to 0.64% by 2027 [26]. - The number of patients with lower gastrointestinal bleeding is expected to grow slightly from 843,200 in 2018 to 859,800 by 2027, with a stable prevalence rate of 0.06% [32]. Summary by Sections Market Size Overview - The gastrointestinal bleeding drug market in China is calculated using the formula: (CF + EG) / 10,000, where C is the number of upper gastrointestinal bleeding patients, F is the annual cost of medication, E is the number of lower gastrointestinal bleeding patients, and G is the annual cost of medication for lower gastrointestinal bleeding [20]. Upper Gastrointestinal Bleeding - The number of patients with upper gastrointestinal bleeding is projected to increase significantly, with a growth rate peaking at 26.74% in 2019 and gradually declining to 8.80% by 2027 [21]. - The annual cost of medication for upper gastrointestinal bleeding remains constant at 6.6 RMB per patient throughout the forecast period [29]. Lower Gastrointestinal Bleeding - The number of patients with lower gastrointestinal bleeding is expected to show minimal growth, with a slight increase from 843,200 in 2018 to 859,800 by 2027 [32]. - The prevalence rate for lower gastrointestinal bleeding remains stable at 0.06% across the forecast period [30]. Population Data - The total population of China is projected to grow from approximately 1.41 billion in 2018 to 1.43 billion by 2027, with a compound annual growth rate of about 0.3% [23]. Prevalence Rates - The prevalence of upper gastrointestinal bleeding is expected to rise from 0.19% in 2018 to 0.64% by 2027, reflecting an increasing trend in incidence [26]. - The prevalence of lower gastrointestinal bleeding remains stable at 0.06% throughout the forecast period [30].